RKDA Arcadia Biosciences, Inc. - Common Stock
NASDAQ · Food Products · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 13, 2026
$0,29
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$0,2252tyg. minimum
$6,7152tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$628.8K
P/E (TTM)
-0.1
EPS (TTM)
$-4.55
Przychody (TTM)
$5M
Twoje odznaki
Zakres 52 tyg.
$0–$7
Ocena Analityków
BUY
Cena Docelowa
·
P/E
-0.1
ROE
-430.9%
Marża Zysku Netto
-234.5%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
RKDA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.29
Kapitalizacja Rynkowa (MRQ)
$628.8K
P/E (TTM)
-0.1
EPS (TTM)
$-4.55
Przychody (TTM)
$5M
ROE (TTM)
-430.9%
Zakres 52 tyg.
$0–$7
RKDA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 1 marca 2023 | 1-for-40 | Odwrotny |
| 24 stycznia 2018 | 1-for-20 | Odwrotny |
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$5M2016-12-31 → 2025-12-31
EPS$-1.712021-12-31 → 2025-12-31
Wolny przepływ pieniężny·2016-12-31 → 2021-12-31
Marża netto-234.5%2016-12-31 → 2021-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | RKDA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -0.1średnia z 5 lat ≈-0.9 | ≈-0.9 | · | · | |
| P/S (TTM) | 0.1 | · | · | · | |
| P/B (MRQ) | 1.0 | · | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 1.1średnia z 5 lat ≈6.6 | ≈6.6 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | RKDA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -80.2% | · | · | · | |
| Marża Zysku Netto (TTM) | -234.5% | · | · | · | |
| ROA (TTM) | -162.7% | · | · | · | |
| ROE (TTM) | -430.9% | · | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | RKDA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 3.5 | · | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | RKDA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -3.7%średnia z 5 lat ≈-7.3% | ≈-7.3% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -13.2%średnia z 5 lat ≈-13.5% | ≈-13.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -9.6% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | RKDA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue / Employee (Przychody / pracownika) | ≈$607.2K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
93.9%
Następny raport
Lis 05, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 września 2025 | $0.62 | $-0.55 | 212.6% | |
| 30 czerwca 2025 | $0.02 | $-0.81 | 102.5% | |
| 31 marca 2025 | $1.90 | $-1.00 | 290.1% | |
| 31 grudnia 2024 | $-2.99 | $-0.91 | -229.4% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $5M | $4M | $7M | $7M | $8M | $1M | $1M | $4M | $3M | $5M | $7M | |
| Cost of Revenue | $3M | $3M | $2M | $6M | $9M | $5M | · | · | $283.0K | $895.0K | $892.0K | $2M | |
| R&D Expense | $9.0K | $53.0K | $64.0K | $2M | $4M | $8M | $7M | $6M | $7M | $9M | $9M | $10M | |
| SG&A Expense | $7M | $10M | $8M | $15M | $23M | $16M | $14M | $12M | $11M | $12M | $11M | $10M | |
| Operating Expenses | $7M | $9M | $11M | $21M | $42M | $21M | $21M | $18M | $18M | $22M | $21M | $22M | |
| Operating Income | $-2M | $-4M | $-6M | $-14M | $-36M | $-13M | $-19M | $-17M | $-14M | $-19M | $-16M | $-15M | |
| Interest Expense | · | · | · | · | $20.0K | $47.0K | $5.0K | · | $747.0K | $1M | $3M | $1M | |
| Other Non-op | $2M | $31.0K | $48.0K | $9.0K | $10M | $740.0K | $466.0K | $394.0K | $281.0K | $340.0K | $521.0K | $-597.0K | |
| Pretax Income | $-2M | $-4M | $-5M | $-11M | $-16M | $-6M | $-29M | $-13M | $-16M | $-20M | $-18M | $-18M | |
| Income Tax | $8.0K | $8.0K | $8.0K | $14.0K | $2.0K | $-124.0K | $2.0K | $10.0K | $26.0K | $25.0K | $26.0K | $263.0K | |
| Net Income | $-2M | $-7M | $-14M | $-15M | $-15M | $-5M | $-29M | $-13M | $-16M | $-20M | $-18M | $-18M | |
| EPS (Basic) | $-1.71 | $-5.17 | $-11.29 | $-25.65 | $-27.56 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.71 | $-5.17 | $-11.29 | $-25.65 | $-27.56 | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,368,057 | 1,363,303 | 1,236,934 | 599,389 | 532,016 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 1,368,057 | 1,363,303 | 1,236,934 | 599,389 | 532,016 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | $-36M | $-13M | $-19M | $-17M | · | $-19M | $-16M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $259.0K | $4M | $7M | $21M | $29M | $14M | $8M | $12M | $9M | $2M | $24M | $17M | |
| Short-term Investments | $4M | $0 | $5M | $0 | · | $12M | $17M | $10M | $4M | $49M | $26M | $0 | |
| Receivables | · | · | · | · | $1M | $1M | $602.0K | $165.0K | $1M | $349.0K | $706.0K | $1M | |
| Inventory | $1M | $904.0K | $837.0K | $2M | $4M | $4M | $2M | $181.0K | $229.0K | $252.0K | $294.0K | $424.0K | |
| Prepaid Expense | $156.0K | $931.0K | $807.0K | $795.0K | $900.0K | $811.0K | $712.0K | $704.0K | $560.0K | $877.0K | $692.0K | $278.0K | |
| Current Assets | $6M | $9M | $15M | $25M | $35M | $32M | $28M | $23M | $15M | $52M | $52M | $19M | |
| PP&E (Net) | $8.0K | $41.0K | $70.0K | $680.0K | $2M | $4M | $2M | $395.0K | $299.0K | $508.0K | $585.0K | $728.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $3M | $8M | $8M | $6M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $2M | $2M | $2M | $3M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Goodwill | · | · | · | · | · | $408.0K | · | · | · | · | · | · | |
| Intangibles | $39.0K | $39.0K | $39.0K | $40.0K | $484.0K | $370.0K | · | · | · | · | · | · | |
| Other Non-current Assets | $143.0K | $92.0K | $164.0K | $165.0K | $180.0K | $23.0K | $8.0K | $7.0K | $56.0K | $19.0K | $25.0K | $3M | |
| Total Assets | $7M | $14M | $20M | $29M | $44M | $47M | $33M | $24M | $17M | $57M | $74M | $25M | |
| Accounts Payable | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $3M | $2M | $2M | $2M | $3M | |
| Short-term Debt | · | · | · | · | · | · | $24.0K | · | · | · | $0 | $1M | |
| Current Liabilities | $2M | $3M | $4M | $4M | $5M | $6M | $6M | $3M | $4M | $3M | $3M | $11M | |
| Capital Leases | · | $0 | $155.0K | $1M | $2M | $5M | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $0 | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Total Liabilities | $2M | $7M | $7M | $8M | $13M | $19M | $24M | $11M | $9M | $34M | $34M | $27M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | $0 | $25M | $25M | $10M | |
| Total Debt | · | · | · | · | $0 | $2M | $24.0K | · | · | $25M | $25M | · | |
| Common Stock | $65.0K | $65.0K | $65.0K | $65.0K | $63.0K | $54.0K | $49.0K | $45.0K | $42.0K | $44.0K | $44.0K | $0 | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $29M | |
| Retained Earnings | $-281M | $-279M | $-272M | $-258M | $-226M | $-212M | $-207M | $-178M | $-167M | $-152M | $-132M | $-114M | |
| AOCI | · | $0 | $101.0K | $0 | · | · | $1.0K | · | $-1.0K | $-19.0K | $-115.0K | $0 | |
| Stockholders' Equity | $4M | $6M | $13M | $21M | $31M | $28M | $8M | $13M | $8M | $22M | $40M | $-85M | |
| Liabilities + Equity | $7M | $14M | $20M | $29M | $44M | $47M | $33M | $24M | $17M | $57M | $74M | $25M | |
| Shares Outstanding | 1,373,120 | 1,364,940 | 1,285,337 | 616,079 | 554,609 | 13,450,861 | 8,646,149 | 4,774,919 | 2,134,154 | 2,224,384 | 44,184,195 | 2,074,030 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $154.0K | $279.0K | $304.0K | $294.0K | $358.0K | |
| Stock-based Comp | $234.0K | $512.0K | $717.0K | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $976.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $-106.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $40.0K | $116.0K | $30.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-10M | $-15M | $-14M | $-26M | $-30M | $-17M | $-14M | $-14M | $-17M | $-15M | $-15M | |
| CapEx | $0 | $16.0K | $5.0K | $72.0K | $1M | $2M | $1M | $250.0K | $79.0K | $231.0K | $151.0K | $148.0K | |
| Investing Cash Flow | $750.0K | $7M | $-4M | $1M | $17M | $17M | $-8M | $-6M | $47M | · | · | · | |
| Financing Cash Flow | $6.0K | $9.0K | $6M | $5M | $22M | $21M | $22M | $22M | $-26M | · | · | · | |
| Net Change in Cash | $-4M | $-2M | $-14M | $-8M | $13M | $8M | $-4M | $3M | $7M | $-22M | $7M | $14M | |
| Free Cash Flow | · | · | · | · | $-27M | $-33M | $-19M | $-14M | · | $-17M | $-15M | · | |
| Levered FCF | · | · | · | · | $-27M | $-33M | $-19M | · | · | $-19M | $-18M | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -524.0% | -159.1% | -1657.9% | -1152.3% | · | -584.1% | -287.5% | · | |
| Net Margin | · | · | · | · | -216.2% | -57.9% | -2464.1% | -920.8% | · | -615.6% | -331.7% | · | |
| Pretax Margin | · | · | · | · | -237.9% | -76.5% | -2469.7% | -920.1% | · | -614.8% | -331.2% | · | |
| EBITDA Margin | · | · | · | · | -524.0% | -159.1% | -1657.9% | -1152.3% | · | -584.1% | -287.5% | · | |
| ROA | · | · | · | · | -32.1% | -11.7% | -101.8% | -66.4% | · | -30.0% | -36.2% | · | |
| ROE | · | · | · | · | -49.9% | -26.3% | -280.8% | -129.5% | · | -62.9% | 80.6% | · | |
| ROIC | · | · | · | · | -114.3% | -42.0% | -250.8% | -131.7% | · | -39.4% | -23.9% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 7.0 | 5.0 | 5.0 | 7.5 | · | 16.7 | 15.1 | · | |
| Quick Ratio | · | · | · | · | 6.0 | 4.3 | 4.5 | 7.2 | · | 16.3 | 14.8 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.1 | 0.0 | · | · | 1.1 | 0.6 | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | 0.1 | · | · | · | 1.1 | 0.6 | · | |
| Interest Coverage | · | · | · | · | -1776.3 | -271.9 | -3876.2 | · | · | -14.1 | -5.9 | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.1 | 0.2 | 0.0 | 0.1 | · | 0.0 | 0.1 | · | |
| Inventory Turnover | · | · | · | · | 2.1 | · | · | · | · | 3.3 | 2.5 | · | |
| Receivables Turnover | · | · | · | · | 4.9 | 8.0 | 3.0 | 2.1 | · | 6.0 | 6.2 | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $1.40 | $2.06 | $0.89 | $2.68 | · | $0.50 | $0.91 | · | |
| Cash / Share | · | · | · | · | $1.29 | $1.04 | $0.97 | $2.51 | · | $0.05 | $0.54 | · | |
| EPS (TTM) | $-1.71 | $-5.17 | $-11.29 | $-25.65 | $-27.56 | $-3.39 | · | · | · | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.7% | 13.3% | -40.0% | 9.4% | -15.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -13.2% | -9.4% | -17.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -9.6% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | $4M | $7M | $7M | $8M | $1M | $1M | $4M | $3M | $5M | · | |
| Net Income TTM | $-2M | $-7M | $-14M | $-15M | $-15M | $-5M | $-29M | $-13M | $-16M | $-20M | $-18M | · | |
| Market Cap | · | · | · | · | $923M | $1.36B | $1.90B | $605M | · | $32.74B | $107.46B | · | |
| Enterprise Value | · | · | · | · | $894M | $1.34B | $1.87B | · | · | $32.72B | $107.43B | · | |
| P/E | -1.2 | -1.1 | -0.3 | -0.4 | -1.5 | -29.9 | · | · | · | · | · | · | |
| P/S | · | · | · | · | 136.1 | 169.4 | 1621.2 | 413.6 | · | 10270.7 | 19847.8 | · | |
| P/B | · | · | · | · | 29.7 | 49.1 | 246.0 | 47.2 | · | 1475.0 | 2671.4 | · | |
| P / Tangible Book | 0.7 | 1.3 | 0.3 | 0.3 | 30.2 | 50.5 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | -35.7 | -45.0 | -110.2 | -44.4 | · | -1919.8 | -7112.0 | · | |
| P / FCF | · | · | · | · | -34.3 | -41.8 | -101.5 | -43.6 | · | -1894.2 | -7041.7 | · | |
| EV / EBITDA | · | · | · | · | -25.2 | -104.7 | -96.5 | · | · | -1757.1 | -6903.0 | · | |
| EV / FCF | · | · | · | · | -33.3 | -41.1 | -100.1 | · | · | -1892.7 | -7040.0 | · | |
| EV / Revenue | · | · | · | · | 131.9 | 166.5 | 1599.6 | · | · | 10262.7 | 19843.1 | · | |
| Earnings Yield | -86.4% | -87.3% | -360.7% | -236.6% | -66.2% | -3.4% | · | · | · | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $1M | $901.0K | $1M | $1M | $1M | $1M | $2M | $1M | $987.0K | $627.0K | $1M | $1M | $1M | $-1M | $2M | |
| Cost of Revenue | $812.0K | $700.0K | $708.0K | $884.0K | $824.0K | $682.0K | $827.0K | $1M | $633.0K | $471.0K | $18.0K | $818.0K | $650.0K | $688.0K | $-2M | $1M | |
| R&D Expense | $0 | · | $0 | $0 | $9.0K | $0 | $13.0K | $24.0K | $10.0K | $6.0K | $-337.0K | $15.0K | $27.0K | $359.0K | $500.0K | $255.0K | |
| SG&A Expense | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $227.0K | $2M | $2M | $4M | $2M | $4M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $670.0K | $3M | $3M | $-674.0K | $3M | $11.0K | $3M | $3M | $5M | $380.0K | $6M | |
| Operating Income | $-496.0K | $-779.0K | $-1M | $-1M | $-501.0K | $530.0K | $-2M | $-2M | $2M | $-2M | $616.0K | $-1M | $-1M | $-4M | $-2M | $-4M | |
| Other Non-op | $-3M | $-2M | $-460.0K | $2M | $1M | $0 | $-137.0K | $15.0K | $150.0K | $3.0K | $12.0K | $17.0K | $-13.0K | $32.0K | $-4.0K | $43.0K | |
| Pretax Income | · | · | · | · | · | · | $-4M | $-1M | $2M | · | $-445.0K | $-639.0K | $3M | · | $-3M | $-2M | |
| Income Tax | · | · | · | · | · | · | $8.0K | $0 | $0 | · | $7.0K | $0 | $1.0K | · | $13.0K | $1.0K | |
| Net Income | $-6M | $-4M | $-1M | $856.0K | $-4M | $3M | $-4M | $-2M | $1M | $-2M | $-3M | $-3M | $823.0K | $-9M | $-4M | $-3M | |
| EPS (Basic) | $-2.09 | $-2.11 | $-0.98 | $0.63 | $-3.26 | $1.90 | $-2.99 | $-1.18 | $0.78 | $-1.78 | $0.85 | $-1.89 | $0.61 | $-10.86 | · | $-4.67 | |
| EPS (Diluted) | $-2.09 | $-2.11 | $-0.97 | $0.62 | $-3.26 | $1.90 | $-2.99 | $-1.18 | $0.78 | $-1.78 | $0.85 | $-1.89 | $0.61 | $-10.86 | · | $-4.67 | |
| Shares (Basic) | 2,992,555 | 2,082,887 | · | 1,367,192 | 1,367,040 | 1,366,060 | · | 1,363,753 | 1,362,840 | 1,361,657 | · | 1,359,511 | 1,358,395 | 864,391 | · | 613,814 | |
| Shares (Diluted) | 2,992,555 | 2,082,887 | · | 1,371,879 | 1,367,040 | 1,366,203 | · | 1,363,753 | 1,362,840 | 1,361,657 | · | 1,359,511 | 1,358,395 | 864,391 | · | 613,814 | |
| EBITDA | $-496.0K | $-779.0K | · | $-1M | $-501.0K | $530.0K | · | $-2M | $2M | $-3M | · | $-3M | $-4M | $-4M | · | $-5M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $954.0K | $259.0K | $1M | $1M | $3M | $4M | $4M | $6M | $3M | $7M | $11M | $13M | $23M | $21M | $23M | |
| Short-term Investments | $0 | $3M | $4M | $5M | $3M | · | $0 | $3M | $3M | $5M | $5M | $5M | $5M | · | $0 | · | |
| Inventory | $930.0K | $840.0K | $1M | $1M | $1M | $1M | $904.0K | $835.0K | $978.0K | $2M | $837.0K | $3M | $3M | $3M | $2M | $3M | |
| Prepaid Expense | $72.0K | $184.0K | $156.0K | $214.0K | $383.0K | $727.0K | $931.0K | $521.0K | $537.0K | $535.0K | $807.0K | $1M | $951.0K | $606.0K | $795.0K | $990.0K | |
| Current Assets | $6M | $5M | $6M | $8M | $8M | $9M | $9M | $11M | $12M | $12M | $15M | $20M | $23M | $27M | $25M | $30M | |
| PP&E (Net) | $0 | $0 | $8.0K | $10.0K | $12.0K | $28.0K | $41.0K | $55.0K | $54.0K | $328.0K | $70.0K | $468.0K | $560.0K | $622.0K | $680.0K | $848.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $6M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $5M | |
| Intangibles | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $40.0K | $40.0K | $40.0K | $40.0K | $373.0K | |
| Other Non-current Assets | $115.0K | $115.0K | $143.0K | $148.0K | $148.0K | $92.0K | $92.0K | $164.0K | $164.0K | $164.0K | $164.0K | $181.0K | $178.0K | $165.0K | $165.0K | $165.0K | |
| Total Assets | $6M | $5M | $7M | $9M | $8M | $13M | $14M | $15M | $17M | $16M | $20M | $23M | $27M | $30M | $29M | $34M | |
| Accounts Payable | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Current Liabilities | $2M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Capital Leases | · | · | · | · | · | · | · | $0 | $11.0K | $21.0K | $155.0K | $347.0K | $532.0K | $760.0K | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $5M | $2M | $2M | $3M | $3M | $4M | $7M | $5M | $6M | $6M | $7M | $8M | $9M | $14M | $8M | $9M | |
| Common Stock | $66.0K | $66.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | |
| Retained Earnings | $-292M | $-286M | $-281M | $-280M | $-281M | $-276M | $-279M | $-275M | $-273M | $-274M | $-272M | $-269M | $-266M | $-267M | $-258M | $-254M | |
| AOCI | · | · | · | · | · | · | · | $117.0K | $81.0K | $161.0K | $101.0K | $87.0K | $21.0K | · | $0 | · | |
| Stockholders' Equity | $633.0K | $3M | $4M | $5M | $5M | $9M | $6M | $10M | $12M | $11M | $13M | $16M | $18M | $17M | $21M | $25M | |
| Liabilities + Equity | $6M | $5M | $7M | $9M | $8M | $13M | $14M | $15M | $17M | $16M | $20M | $23M | $27M | $30M | $29M | $34M | |
| Shares Outstanding | 2,181,715 | 2,056,884 | 1,373,120 | 1,367,429 | 1,367,040 | 1,367,040 | 1,364,940 | 1,364,940 | 1,362,840 | 1,362,840 | 1,285,337 | 1,110,337 | 1,108,432 | 857,572 | 616,079 | 24,642,960 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14.0K | $15.0K | $17.0K | $53.0K | $86.0K | $78.0K | $117.0K | $155.0K | $102.0K | $138.0K | $144.0K | $162.0K | $199.0K | $212.0K | $209.0K | $314.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $1.0K | $13.0K | |
| Operating Cash Flow | $-319.0K | $-1M | $-861.0K | $-257.0K | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-4M | $-3M | $-5M | $-3M | $-2M | $-3M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $3.0K | $13.0K | $0 | $0 | $5.0K | $0 | $26.0K | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $250.0K | $500.0K | $3M | $180.0K | $5M | $4.0K | $52.0K | $5.0K | $-5M | $315.0K | $281.0K | $341.0K | |
| Financing Cash Flow | $4M | $2M | $0 | $1.0K | $0 | $5.0K | $0 | $4.0K | $0 | $5.0K | $0 | $7.0K | $0 | $6M | $0 | $5M | |
| Net Change in Cash | $3M | $695.0K | $-861.0K | $-256.0K | $-2M | $-1M | $306.0K | $-2M | $2M | $-3M | $-4M | $-3M | $-10M | $2M | $-2M | $1M | |
| Free Cash Flow | · | · | · | · | · | $-2M | · | · | · | $-3M | · | · | · | $-3M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -34.4% | -70.8% | · | -88.5% | -34.4% | 44.2% | · | -114.5% | 151.6% | -244.1% | · | -203.0% | -272.9% | -268.3% | · | -243.9% | |
| Net Margin | -434.2% | -398.6% | · | 65.8% | -306.4% | 216.6% | · | -104.9% | 81.2% | -193.1% | · | -160.7% | 59.2% | -621.9% | · | -152.7% | |
| Pretax Margin | · | · | · | · | · | · | · | -76.9% | 141.7% | · | · | -155.5% | · | · | · | · | |
| EBITDA Margin | -34.4% | -70.8% | · | -88.5% | -34.4% | 44.2% | · | -114.5% | 151.6% | -244.1% | · | -203.0% | -272.9% | -268.3% | · | -243.9% | |
| ROA | -91.6% | -47.9% | · | 7.2% | -35.4% | 17.9% | · | -8.3% | 4.8% | -10.4% | · | -8.9% | 2.7% | -27.1% | · | -6.1% | |
| ROE | -242.6% | -74.4% | · | 10.9% | -54.9% | 26.6% | · | -12.5% | 7.2% | -17.7% | · | -12.6% | 3.7% | -39.9% | · | -8.8% | |
| ROIC | · | · | · | · | · | · | · | -17.1% | 16.9% | · | · | -20.9% | · | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.8 | · | 3.7 | 4.1 | 4.0 | · | 4.6 | 4.6 | 4.0 | · | 5.1 | 5.7 | 6.6 | · | 7.4 | |
| Quick Ratio | 2.5 | 2.7 | · | 2.6 | 2.4 | 1.4 | · | 2.8 | 3.0 | 3.0 | · | 4.0 | 4.5 | 5.6 | · | 5.6 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.7 | 0.4 | · | 0.6 | 0.3 | 0.4 | · | 0.4 | 0.3 | 0.3 | · | 0.3 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.29 | $1.40 | · | $3.98 | $3.32 | $6.51 | · | $7.54 | $8.59 | $7.79 | · | $13.99 | $16.12 | $19.62 | · | $1.02 | |
| Revenue / Share | $0.48 | $0.53 | · | $0.95 | $1.06 | $0.88 | · | $1.13 | $0.96 | $0.92 | · | $1.17 | $1.02 | $1.75 | · | $0.08 | |
| Cash Flow / Share | · | $-0.53 | · | · | · | $-1.16 | · | · | · | $-2.36 | · | · | · | $-4.01 | · | · | |
| Cash / Share | $1.92 | $0.46 | · | $0.82 | $1.01 | $2.31 | · | $2.88 | $4.04 | $2.43 | · | $9.56 | $12.16 | $26.82 | · | $0.92 | |
| EPS (TTM) | $-4.55 | $-5.72 | · | $-3.73 | $-5.53 | $-1.49 | · | $-1.33 | $-2.04 | $-2.21 | · | · | · | · | · | $-46.90 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | · | $5M | $5M | $5M | · | $4M | $4M | $4M | · | $3M | $3M | $5M | · | $11M | |
| Net Income TTM | $-11M | $-9M | · | $-5M | $-8M | $-2M | · | $-6M | $-7M | $-7M | · | $-15M | $-16M | $-20M | · | $-20M | |
| Market Cap | $1M | $3M | · | $5M | $6M | $4M | · | $4M | $4M | $3M | · | $4M | $4M | $6M | · | $520M | |
| P/E | -0.1 | -0.2 | · | -0.9 | -0.8 | -2.0 | · | -2.1 | -1.5 | -1.0 | · | · | · | · | · | -0.5 | |
| P/S | 0.3 | 0.6 | · | 0.9 | 1.1 | 0.8 | · | 0.8 | 1.0 | 0.7 | · | 1.4 | 1.5 | 1.2 | · | 48.1 | |
| P/B | 2.3 | 1.0 | · | 0.9 | 1.3 | 0.5 | · | 0.4 | 0.4 | 0.3 | · | 0.2 | 0.2 | 0.4 | · | 20.8 | |
| P / Tangible Book | 2.5 | 1.0 | · | 0.9 | 1.3 | 0.5 | · | 0.4 | 0.4 | 0.3 | · | 0.2 | 0.2 | 0.4 | · | 21.1 | |
| P / Cash Flow | · | -2.6 | · | · | · | -2.6 | · | · | · | -0.9 | · | · | · | -1.8 | · | · | |
| Earnings Yield | -670.1% | -414.5% | · | -107.5% | -128.4% | -50.2% | · | -48.7% | -64.8% | -100.0% | · | · | · | · | · | -222.1% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $5M | $5M | $4M | $7M | $7M |
| Marża Operacyjna % | · | · | · | · | -524.0% |
| Zysk netto | $-2M | $-7M | $-14M | $-15M | $-15M |
| Rozwodniony EPS | $-1.71 | $-5.17 | $-11.29 | $-25.65 | $-27.56 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | · | · | · | · | 0.0 |
| Wskaźnik bieżący | · | · | · | · | 7.0 |
| Wskaźnik Szybkości | · | · | · | · | 6.0 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | · | · | · | · | $-27M |
Właściciele instytucjonalni (13F) 18 emitentów · $99K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
18
Wartość posiadanych akcji
$99K
Nowe pozycje
8
Zamknięte pozycje
7
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 8 (+1 vs poprzedni kw.) | 7 (+5 vs poprzedni kw.) | 0 (-3 vs poprzedni kw.) | 2 (+2 vs poprzedni kw.) | -138K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $27 795 | 14 038 | 28,18% | Akcje |
| CITADEL ADVISORS LLC | $16 120 | 23 738 | 16,34% | Akcje |
| StoneX Group Inc. | $11 259 | 13 682 | 11,41% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $10 957 | 16 135 | 11,11% | Akcje |
| XTX Topco Ltd | $10 509 | 15 475 | 10,65% | Akcje |
| STATE STREET CORP | $8 248 | 12 146 | 8,36% | Akcje |
| JANE STREET GROUP, LLC | $6 957 | 10 245 | 7,05% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 548 | 9 644 | 6,64% | Akcje |
| SBI Securities Co., Ltd. | $81 | 120 | 0,08% | Akcje |
| HRT FINANCIAL LP | $60 | 88 386 | 0,06% | Akcje |
| TD Waterhouse Canada Inc. | $50 | 70 | 0,05% | Akcje |
| UBS Group AG | $24 | 35 | 0,02% | Akcje |
| Virtu Financial LLC | $15 | 21 786 | 0,02% | Akcje |
| GROUP ONE TRADING LLC | $12 | 18 | 0,01% | Akcje |
| HARBOUR INVESTMENTS, INC. | $1 | 1 | 0,00% | Akcje |
| MORGAN STANLEY | $1 | 2 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Akcje |
| SOUTHERN MICHIGAN BANK & TRUST | $1 | 2 | 0,00% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Moral Compass Corporation, Terri Bishop, Peter Sperling, Darby Shupp, John G. Sperling 2012 Irrevocable Trust No. 1, John G. Sperling 2012 Irrevocable Trust No. 2, John G. Sperling 2012 Irrevocable Trust No. 3 ×4 zgłoszenia | 20 stycznia 2023 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 30 insiderów · 16 dyrektorzy generalni · 15 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Thomas J. Schaefer | Chief Executive Officer | 9 maja 2025 A | 2 819 | 0 | 0 | $0 |
| Stanley Jacot Jr | Chief Executive Officer | 30 maja 2023 P | 5 000 | 0 | 0 | $0 |
| Matthew T Plavan | Chief Executive Officer | 21 stycznia 2021 A | 14 285 | 0 | 0 | $0 |
| Rajendra D. Ketkar | Chief Executive Officer | 3 czerwca 2019 A | · | 0 | 0 | $0 |
| Mark Kawakami | Chief Financial Officer | 9 maja 2025 A | 2 681 | 0 | 0 | $0 |
| Pamela Haley | Chief Financial Officer | 16 sierpnia 2022 A | 5 088 | 0 | 0 | $0 |
| Roger Salameh | Chief Operating Officer | 18 sierpnia 2016 A | 11 415 | 0 | 0 | $0 |
| Laura Pitlik | Chief Marketing Officer | 4 kwietnia 2023 A | · | 0 | 0 | $0 |
| Chris Cuvelier | Chief Growth Officer | 17 maja 2021 A | · | 0 | 0 | $0 |
| Randall Shultz | Chief Technology Officer | 21 stycznia 2021 A | 13 000 | 0 | 0 | $0 |
| Sarah Reiter | Chief Commercial Officer | 3 lutego 2020 A | 3 800 | 0 | 0 | $0 |
| Zhongjin Lu | VP Product Development | 23 marca 2018 M | 558 | 0 | 0 | $0 |
| Vic C. Knauf | Chief Scientific Officer | 18 sierpnia 2016 A | 47 134 | 0 | 0 | $0 |
| Wendy S. Neal | VP, Chief Legal Officer | 18 sierpnia 2016 A | · | 0 | 0 | $0 |
| Steven F. Brandwein | Interim Chief Financ. Officer | 13 czerwca 2016 S | 750 | 0 | 0 | $0 |
| Don Emlay | VP Regulatory and Compliance | 14 września 2015 M | 17 729 | 0 | 0 | $0 |
| Lilian Shackelford Murray | Dyrektor | 10 września 2026 A | 8 524 | 0 | 0 | $0 |
| Kevin Comcowich | Dyrektor | 10 września 2026 A | 20 000 | 0 | 0 | $0 |
| Amy Yoder | Dyrektor | 10 września 2026 A | · | 0 | 0 | $0 |
| Gregory D Waller | Dyrektor | 10 września 2026 A | · | 0 | 0 | $0 |
| Deborah D Carosella | Dyrektor | 19 sierpnia 2024 A | · | 0 | 0 | $0 |
| Albert D. Bolles | Dyrektor | 19 sierpnia 2024 A | · | 0 | 0 | $0 |
| Eric J. Rey | Dyrektor | 3 czerwca 2019 A | 7 335 | 0 | 0 | $0 |
| Uday Garg | Dyrektor | 7 czerwca 2017 A | 9 080 808 | 0 | 0 | $0 |
| George Frederick John Gosbee | Dyrektor | 7 czerwca 2017 A | · | 0 | 0 | $0 |
| Darby E Shupp | Dyrektor | 18 sierpnia 2016 A | 22 515 364 | 0 | 0 | $0 |
| James Richard Reis | Dyrektor | 1 października 2015 M | 50 000 | 0 | 0 | $0 |
| Mark Wong | Dyrektor | 9 września 2015 M | 5 000 | 0 | 0 | $0 |
| Matthew A. Ankrum | Dyrektor | 20 maja 2015 A | · | 0 | 0 | $0 |
| Rajiv Shah | · | 18 sierpnia 2016 A | · | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 9 644 SH | 19 sierpnia 2026 | Dziennie |
RKDA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 7 analityków
KUP
2 28,6%
Mocne kupno
4 57,1%
Kup
1 14,3%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 13, 2026